MENU
OGEN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Oragenics (OGEN) Ownership - Who owns Oragenics?

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
9015 Town Center Parkway
Phone
+1 813 286-7900
Employees
4
Web
https://www.oragenics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.65M
P/E Ratio
0.02
Total Cash
6.11M
Projected Growth
N/A
Total Debt
56.13K
Revenue
N/A
Risk (Beta)
1.92
Dividend Yield
N/A
Total Cash/Share
1.35
Total Debt/Equity
0.57
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
OGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
9015 Town Center Parkway
Phone
+1 813 286-7900
Employees
4
Web
https://www.oragenics.com